Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11906-021-01153-6 http://scihub22266oqcxt.onion/10.1007/s11906-021-01153-6 34189678!8241408!34189678     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34189678&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Hypertens+Rep 2021 ; 23 (6): 36 Nephropedia Template TP {{tp|p=34189678|t=2021. Hypertension, Obesity, and COVID-19: a Collision of Pandemics |pdf=|usr=}}{{34189678}} gab.com Text Hypertension, Obesity, and COVID-19: a Collision of Pandemics JO: Curr Hypertens Rep http://www.kidney.de/pget.php?&tw=1&pmid=34189678 #FOAvip To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also been seen historically in other viral illnesses. Understanding the mechanisms behind the associations between COVID-19, hypertension, and obesity is important in developing effective targeted therapies and monitoring vaccine response and efficacy. More research is needed to apply our growing knowledge of the pathophysiology of COVID-19, hypertension, and obesity to prevention and treatment. Interventions focusing on lifestyle modification in managing hypertension and obesity can potentially have a positive impact on containing this pandemic and future viral illness outbreaks. Twit Text FOAVip Hypertension, Obesity, and COVID-19: a Collision of Pandemics ????Curr Hypertens Rep http://www.kidney.de/pget.php?&tw=1&pmid=34189678 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34189678 #FOAvip English Wikipedia <ref>{{Cite pmid|34189678}}</ref> Hypertension, Obesity, and COVID-19: a Collision of Pandemics #MMPMID34189678 Perez A; Naljayan M; Shuja I; Florea A; Reisin E Curr Hypertens Rep 2021[Jun]; 23 (6): 36 PMID34189678show ga To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also been seen historically in other viral illnesses. Understanding the mechanisms behind the associations between COVID-19, hypertension, and obesity is important in developing effective targeted therapies and monitoring vaccine response and efficacy. More research is needed to apply our growing knowledge of the pathophysiology of COVID-19, hypertension, and obesity to prevention and treatment. Interventions focusing on lifestyle modification in managing hypertension and obesity can potentially have a positive impact on containing this pandemic and future viral illness outbreaks. |*COVID-19[MESH] |*Hypertension[MESH] |Humans[MESH] |Obesity[MESH] |Pandemics[MESH] |Renin-Angiotensin System[MESH]Hypertension, Obesity, and COVID-19: a Collision of Pandemics (epmc).pdf DeepDyve Pubget Overpricing